These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 34675415)

  • 41. Gut Microbiota and Development of Vibrio cholerae-Specific Long-Term Memory B Cells in Adults after Whole-Cell Killed Oral Cholera Vaccine.
    Chac D; Bhuiyan TR; Saha A; Alam MM; Salma U; Jahan N; Chowdhury F; Khan AI; Ryan ET; LaRocque R; Harris JB; Qadri F; Weil AA
    Infect Immun; 2021 Aug; 89(9):e0021721. PubMed ID: 34228490
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Modulation of Host-Microbe Metabolism by Cholera Toxin.
    Chapman CML; Kapinos A; Rivera-Chávez F
    Infect Immun; 2023 May; 91(5):e0043522. PubMed ID: 37022166
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Molecular analysis of Vibrio cholerae O1, O139, non-O1, and non-O139 strains: clonal relationships between clinical and environmental isolates.
    Singh DV; Matte MH; Matte GR; Jiang S; Sabeena F; Shukla BN; Sanyal SC; Huq A; Colwell RR
    Appl Environ Microbiol; 2001 Feb; 67(2):910-21. PubMed ID: 11157262
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Antagonism toward the intestinal microbiota and its effect on
    Zhao W; Caro F; Robins W; Mekalanos JJ
    Science; 2018 Jan; 359(6372):210-213. PubMed ID: 29326272
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Promotion of colonization and virulence by cholera toxin is dependent on neutrophils.
    Queen J; Satchell KJ
    Infect Immun; 2013 Sep; 81(9):3338-45. PubMed ID: 23798539
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Host cell contact induces expression of virulence factors and VieA, a cyclic di-GMP phosphodiesterase, in Vibrio cholerae.
    Dey AK; Bhagat A; Chowdhury R
    J Bacteriol; 2013 May; 195(9):2004-10. PubMed ID: 23435982
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Danio rerio as a Native Host Model for Understanding Pathophysiology of Vibrio cholerae.
    Mitchell KC; Withey JH
    Methods Mol Biol; 2018; 1839():97-102. PubMed ID: 30047057
    [TBL] [Abstract][Full Text] [Related]  

  • 48. The 1.9 Å crystal structure of the extracellular matrix protein Bap1 from
    Kaus K; Biester A; Chupp E; Lu J; Visudharomn C; Olson R
    J Biol Chem; 2019 Oct; 294(40):14499-14511. PubMed ID: 31439670
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Protective effects of egg yolk immunoglobulins (IgYs) developed against recombinant immunogens CtxB, OmpW and TcpA on infant mice infected with Vibrio cholerae.
    Taheri F; Nazarian S; Ahmadi TS; Gargari SLM
    Int Immunopharmacol; 2020 Dec; 89(Pt B):107054. PubMed ID: 33065385
    [TBL] [Abstract][Full Text] [Related]  

  • 50. MlrA, a MerR family regulator in
    Wu J; Liu Y; Li W; Li F; Liu R; Sun H; Qin J; Feng X; Huang D; Liu B
    Gut Microbes; 2022; 14(1):2143216. PubMed ID: 36369865
    [No Abstract]   [Full Text] [Related]  

  • 51. Characterization of Vibrio cholerae O139 synonym Bengal isolated from patients with cholera-like disease in Bangladesh.
    Higa N; Honma Y; Albert MJ; Iwanaga M
    Microbiol Immunol; 1993; 37(12):971-4. PubMed ID: 8133802
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Vibrio cholerae represses polysaccharide synthesis to promote motility in mucosa.
    Liu Z; Wang Y; Liu S; Sheng Y; Rueggeberg KG; Wang H; Li J; Gu FX; Zhong Z; Kan B; Zhu J
    Infect Immun; 2015 Mar; 83(3):1114-21. PubMed ID: 25561707
    [TBL] [Abstract][Full Text] [Related]  

  • 53. A polyvalent multiepitope protein cross-protects against
    Upadhyay I; Li S; Ptacek G; Seo H; Sack DA; Zhang W
    Proc Natl Acad Sci U S A; 2022 Dec; 119(50):e2202938119. PubMed ID: 36469767
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Analysis of the roles of antilipopolysaccharide and anti-cholera toxin immunoglobulin A (IgA) antibodies in protection against Vibrio cholerae and cholera toxin by use of monoclonal IgA antibodies in vivo.
    Apter FM; Michetti P; Winner LS; Mack JA; Mekalanos JJ; Neutra MR
    Infect Immun; 1993 Dec; 61(12):5279-85. PubMed ID: 8225601
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Silence is golden: gene silencing of V. cholerae during intestinal colonization delivers new aspects to the acid tolerance response.
    Cakar F; Zingl FG; Schild S
    Gut Microbes; 2019; 10(2):228-234. PubMed ID: 30110191
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Identification of novel factors involved in colonization and acid tolerance of Vibrio cholerae.
    Merrell DS; Hava DL; Camilli A
    Mol Microbiol; 2002 Mar; 43(6):1471-91. PubMed ID: 11952899
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Transposon Sequencing of Vibrio cholerae in the Infant Rabbit Model of Cholera.
    Shull LM; Camilli A
    Methods Mol Biol; 2018; 1839():103-116. PubMed ID: 30047058
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Biological activities of lipopolysaccharide isolated from Vibrio cholerae O139, a new epidemic strain for recent cholera in Indian subcontinent.
    Shimizu T; Yanagihara Y; Isshiki Y; Kawamata Y; Kondo S; Hisatsune K
    Microbiol Immunol; 1994; 38(6):471-4. PubMed ID: 7968678
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Comparative proteomic analysis reveals activation of mucosal innate immune signaling pathways during cholera.
    Ellis CN; LaRocque RC; Uddin T; Krastins B; Mayo-Smith LM; Sarracino D; Karlsson EK; Rahman A; Shirin T; Bhuiyan TR; Chowdhury F; Khan AI; Ryan ET; Calderwood SB; Qadri F; Harris JB
    Infect Immun; 2015 Mar; 83(3):1089-103. PubMed ID: 25561705
    [TBL] [Abstract][Full Text] [Related]  

  • 60. ToxR Mediates the Antivirulence Activity of Phenyl-Arginine-β-Naphthylamide To Attenuate Vibrio cholerae Virulence.
    Weng Y; Bina TF; Bina XR; Bina JE
    Infect Immun; 2021 Jun; 89(7):e0014721. PubMed ID: 33941578
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.